Treatment of lower-risk myelodysplastic syndromes
Myelodysplastic neoplasms (MDS) involve clonal hematopoiesis and cellular dysplasia, driven by genetic and epigenetic alterations. Spliceosome mutations and epigenetic dysregulation underscore the intricate pathogenesis of MDS. The bone marrow microenvironment, stromal dysfunction, chronic inflamma...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Ferrata Storti Foundation
2024-10-01
|
| Reeks: | Haematologica |
| Online toegang: | https://haematologica.org/article/view/11799 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|